Non-Alcoholic Steatohepatitis and GB Virus-C/Hepatitis G Virus Infection: Is There a Causal Relationship?

Internal Medicine

Volumn 36, Issue 4, 1997, Pages 236-237

  Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY LIVER; FLAVIVIRUS; HUMAN; JAPAN; NOTE; PATHOLOGY; VIRUS HEPATITIS;

FATTY LIVER; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN;

EID: 0031110464     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.236     Document Type: Article

References (18)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Cili Proc 55:434, 1980.
2. Propst A, Propst T, Judmaier G, Vogel W. Prognosis in nonalcoholic steatohepatitis. Gastroenterology 108: 1607, 1995.
3. Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 27:521, 1992.
4. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74, 1990.
5. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 126: 137, 1997.
6. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1: 707, 1981.
7. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103,1994.
8. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564, 1995.
9. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505, 1996.
10. Nakatsuji Y, Shih JWK, Tanaka E, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepat 3: 307, 1996.
11. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 334: 1356, 1996.
12. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 125: 772, 1996.
13. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346: 1131, 1995.
14. Heriglake S, Osterkamp S, Trautwein C, et al. Association between fulminant hepatic failure and a strain of GB V virus C. Lancet 348: 1626, 1996.
15. Saito H, Ebinuma H, Kuramochi S, et al. Chronic hepatitis infected with hepatitis GB virus type C/Hepatitis G virus presenting as non-alcoholic steatohepatitis. Intern Med 36: 283, 1997.
16. Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in “ground-glass” hepatocyte of carries. Arch Pathol 96: 327, 1973.
17. Dienes HP, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology 2: 562, 1982.
18. Fisher RL, Anderson DW, Boyer JL, et al. A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis: The National Cooperative Gallstone Study. Hepatology 2: 187, 1982.